Card
Series GSE226321 Query DataSets for GSE226321
Status Public on Apr 01, 2025
Title Multimodal integration of transcriptomics, proteomics and radiomics improves prediction of recurrence in patients with IDH-mutant Glioma
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Isocitrate dehydrogenase mutant gliomas remain lethal brain cancers which impair quality of life in young adults. These tumors are molecularly and cellularly heterogeneous and have a wide range of survival prognoses. Consequently, the identification of pa
Here, we analyzed imaging, transcriptomic, and proteomic profiles using machine learning to 1) describe the biological characterization of subtypes of IDH-mutant gliomas categorized by PET and histology, 2) reinforce the integration of PET metrics in the
 
Overall design Patient samples were collected during tumor resection and snap-frozen. RNAs were isolated from 59 patients with IDH-mutant gliomas and subjected to RNA sequencing.
 
Contributor(s) Bikfalvi A, Chouleur T, Etchegaray C, Villain L, Lesur A, Ferté T, Rossi M, Andrique L, Simoncini C, Giacobbi A, Gambaretti M, Lopci E, Fernades B, Dittmar Olivier G, Bjerkvig R, Hejblum B, Thiébaut R, Saut O, Bello L
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Feb 28, 2023
Last update date Apr 01, 2025
Contact name Andreas Bikfalvi
E-mail(s) andreas.bikfalvi@u-bordeaux.fr
Organization name University of Bordeaux
Lab U1312 BRIC
Street address Allée Geoffroy St-Hilaire
City Pessac
ZIP/Postal code 33615
Country France
 
Platforms (1)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)